These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 37762460)
41. Complexation of fisetin with novel cyclosophoroase dimer to improve solubility and bioavailability. Jeong D; Choi JM; Choi Y; Jeong K; Cho E; Jung S Carbohydr Polym; 2013 Aug; 97(1):196-202. PubMed ID: 23769537 [TBL] [Abstract][Full Text] [Related]
42. An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS). Truzzi F; Tibaldi C; Zhang Y; Dinelli G; D Amen E Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073709 [TBL] [Abstract][Full Text] [Related]
43. Delivery of synergistic polyphenol combinations using biopolymer-based systems: Advances in physicochemical properties, stability and bioavailability. Zhang L; McClements DJ; Wei Z; Wang G; Liu X; Liu F Crit Rev Food Sci Nutr; 2020; 60(12):2083-2097. PubMed ID: 31257900 [TBL] [Abstract][Full Text] [Related]
44. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability. Dudhipala N; Veerabrahma K Ther Deliv; 2017 Feb; 8(2):79-88. PubMed ID: 28088883 [TBL] [Abstract][Full Text] [Related]
45. Two dietary polyphenols, fisetin and luteolin, reduce inflammation but augment DNA damage-induced toxicity in human RPE cells. Hytti M; Szabó D; Piippo N; Korhonen E; Honkakoski P; Kaarniranta K; Petrovski G; Kauppinen A J Nutr Biochem; 2017 Apr; 42():37-42. PubMed ID: 28113103 [TBL] [Abstract][Full Text] [Related]
46. Improving the Treatment Effect of Carotenoids on Alzheimer's Disease through Various Nano-Delivery Systems. Su W; Xu W; Liu E; Su W; Polyakov NE Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108814 [TBL] [Abstract][Full Text] [Related]
47. Opportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: A novel delivery system perspective. Yuan D; Guo Y; Pu F; Yang C; Xiao X; Du H; He J; Lu S Food Chem; 2024 Jan; 430():137115. PubMed ID: 37566979 [TBL] [Abstract][Full Text] [Related]
49. Interactions affecting the bioavailability of dietary polyphenols in vivo. Scholz S; Williamson G Int J Vitam Nutr Res; 2007 May; 77(3):224-35. PubMed ID: 18214024 [TBL] [Abstract][Full Text] [Related]
50. Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study. Krishnakumar IM; Jaja-Chimedza A; Joseph A; Balakrishnan A; Maliakel B; Swick A J Nutr Sci; 2022; 11():e74. PubMed ID: 36304817 [TBL] [Abstract][Full Text] [Related]
51. Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment. Vazhappilly CG; Amararathna M; Cyril AC; Linger R; Matar R; Merheb M; Ramadan WS; Radhakrishnan R; Rupasinghe HPV J Nutr Biochem; 2021 Aug; 94():108623. PubMed ID: 33705948 [TBL] [Abstract][Full Text] [Related]
52. Biotransformation and Gut Microbiota-Mediated Bioactivity of Flavonols. Wang M; Lu Y; Wu Q; Chen G; Zhao H; Ho CT; Li S J Agric Food Chem; 2023 Jun; 71(22):8317-8331. PubMed ID: 37249228 [TBL] [Abstract][Full Text] [Related]
53. Absorption Profile of (Poly)Phenolic Compounds after Consumption of Three Food Supplements Containing 36 Different Fruits, Vegetables, and Berries. Bresciani L; Martini D; Mena P; Tassotti M; Calani L; Brigati G; Brighenti F; Holasek S; Malliga DE; Lamprecht M; Del Rio D Nutrients; 2017 Feb; 9(3):. PubMed ID: 28245627 [TBL] [Abstract][Full Text] [Related]
54. A comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model Aurora kinase inhibitors. Gollapudi P; Hasegawa LS; Eastmond DA Mutat Res Genet Toxicol Environ Mutagen; 2014 Jun; 767():37-43. PubMed ID: 24680981 [TBL] [Abstract][Full Text] [Related]
55. Designing food structure and composition to enhance nutraceutical bioactivity to support cancer inhibition. McClements DJ; Xiao H Semin Cancer Biol; 2017 Oct; 46():215-226. PubMed ID: 28596014 [TBL] [Abstract][Full Text] [Related]
56. Protective effects of fisetin in an Aβ1-42-induced rat model of Alzheimer's disease. Wang Y; Wu X; Ren W; Liu Y; Dai X; Wang S; Huo Q; Sun Y Folia Neuropathol; 2023; 61(2):196-208. PubMed ID: 37587894 [TBL] [Abstract][Full Text] [Related]
57. A comprehensive overview on the micro- and nano-technological encapsulation advances for enhancing the chemical stability and bioavailability of carotenoids. Soukoulis C; Bohn T Crit Rev Food Sci Nutr; 2018 Jan; 58(1):1-36. PubMed ID: 26065668 [TBL] [Abstract][Full Text] [Related]
58. Mangiferin: a review of dietary sources, absorption, metabolism, bioavailability, and safety. Mei S; Perumal M; Battino M; Kitts DD; Xiao J; Ma H; Chen X Crit Rev Food Sci Nutr; 2023; 63(18):3046-3064. PubMed ID: 34606395 [TBL] [Abstract][Full Text] [Related]
59. Fisetin provides antidepressant effects by activating the tropomyosin receptor kinase B signal pathway in mice. Wang Y; Wang B; Lu J; Shi H; Gong S; Wang Y; Hamdy RC; Chua BHL; Yang L; Xu X J Neurochem; 2017 Dec; 143(5):561-568. PubMed ID: 28945929 [TBL] [Abstract][Full Text] [Related]
60. Fisetin attenuates doxorubicin-induced cardiotoxicity by inhibiting the insulin-like growth factor II receptor apoptotic pathway through estrogen receptor-α/-β activation. Lin KH; Ramesh S; Agarwal S; Kuo WW; Kuo CH; Chen MY; Lin YM; Ho TJ; Huang PC; Huang CY Phytother Res; 2023 Sep; 37(9):3964-3981. PubMed ID: 37186468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]